More than 1 million curable sexually transmitted infections (STIs) are acquired every day worldwide in people 15-49 years old, most of which are asymptomatic.1 FDA CLIA-waived tests broaden access to ...

The ongoing trial is testing the therapy – RBX2660 – as a treatment for Clostridioides difficile infection or C. diff, a bacterium that causes diarrhoea and inflammation in the colon and is a ...

diff, but its first attempt missed the mark in a phase 3 trial and it is now advancing an updated formulation through mid-stage clinical testing. In the phase 3 ECOSPOR trial, patients who took ...

US FDA grants 510(k) clearance and CLIA waiver to Roche’s cobas liat sexually transmitted infection multiplex assay panels: Basel Thursday, January 23, 2025, 09:00 Hrs [IST] Roc ...

Advanced Instruments, the leading supplier in osmolality testing, announces the newest update to its clinical line of freezing point osmometers. The OsmoPRO® MAX is designed for clinical laboratories ...

The UN Food and Agriculture Organization (FAO) has issued a call for data and experts relating to parasites in food.

Like many others, Sadhbh O'Sullivan ditched dairy when she became convinced it was the cause of her 'digestive discomfort'.

Sage Therapeutics, Inc. ("Sage" or "the Company"), today announced that its Board of Directors has initiated a process to explore strategic alternatives for the Company. The Board intends to evaluate ...

Your doctor may order tests to check for osteoporosis while ... Severe diarrhea warning: This drug can cause diarrhea associated with Clostridium difficile (C. diff) bacteria.

Tests broaden access to accurate, easy-to-use diagnostics for patients in a decentralised setting Roche has been granted US ...

cobas HSV 1 and 2 Test, cobas C.diff Test, cobas CT/NG Test (chlamydia/gonorrhea), cobas HPV Test, cobas BRAF V600 Mutation Test, cobas EGFR Mutation Test, and the cobas KRAS Mutation Test.